Current treatment options for HER2-positive breast cancer patients with brain metastases

MLA

Alessandro Inno, et al. “Current Treatment Options for HER2-Positive Breast Cancer Patients with Brain Metastases.” Critical Reviews in Oncology/Hematology, vol. 161, May 2021, p. 103329. EBSCOhost, https://doi.org/10.1016/j.critrevonc.2021.103329.

APA

Alessandro Inno, Antonio Russo, Maria La Vecchia, Nicolò Borsellino, Stefania Gori, Lorena Incorvaia, & Daniele Galanti. (2021). Current treatment options for HER2-positive breast cancer patients with brain metastases. Critical Reviews in Oncology/Hematology, 161, 103329. https://doi.org/10.1016/j.critrevonc.2021.103329

Chicago

Alessandro Inno, Antonio Russo, Maria La Vecchia, Nicolò Borsellino, Stefania Gori, Lorena Incorvaia, and Daniele Galanti. 2021. “Current Treatment Options for HER2-Positive Breast Cancer Patients with Brain Metastases.” Critical Reviews in Oncology/Hematology 161 (May): 103329. doi:10.1016/j.critrevonc.2021.103329.